INTRONA, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 499
NA - Nord America 448
EU - Europa 112
Totale 1.059
Nazione #
HK - Hong Kong 472
US - Stati Uniti d'America 447
SE - Svezia 42
IT - Italia 22
CN - Cina 18
DE - Germania 18
GB - Regno Unito 16
VN - Vietnam 6
FR - Francia 5
BE - Belgio 4
PL - Polonia 3
CA - Canada 1
FI - Finlandia 1
IE - Irlanda 1
IN - India 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
Totale 1.059
Città #
Chandler 75
Fairfield 66
Woodbridge 45
Ashburn 41
Nyköping 36
Seattle 33
Wilmington 25
Cambridge 23
Houston 19
Ann Arbor 17
New York 11
Lawrence 9
Roxbury 9
Beijing 8
Dong Ket 6
Inglewood 6
Bari 5
Des Moines 5
Nanjing 5
Brussels 4
Conversano 4
London 4
Marseille 4
Mottola 4
Brooklyn 3
Taranto 3
Hong Kong 2
Hounslow 2
Milan 2
Redmond 2
Redwood City 2
St Albans 2
West Jordan 2
Dearborn 1
Dublin 1
Edinburgh 1
Guangzhou 1
Hebei 1
Hefei 1
Helsinki 1
Kilburn 1
Martina Franca 1
Paris 1
Princeton 1
Pune 1
San Diego 1
Shenyang 1
Southwark 1
Tianjin 1
Toronto 1
Vientiane 1
Totale 502
Nome #
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 591
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 129
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 109
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 78
Multiparametric unconventional MRI study in early stage of ALS disease 72
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 35
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 35
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 32
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 22
Totale 1.103
Categoria #
all - tutte 3.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 3 6 10
2019/2020160 27 6 3 15 16 9 13 17 15 9 23 7
2020/2021143 2 25 30 10 8 10 10 9 5 15 7 12
2021/2022571 3 8 11 4 4 6 3 9 4 4 13 502
2022/2023161 19 28 14 10 24 13 1 22 24 0 3 3
2023/202445 1 6 4 8 5 12 1 4 2 2 0 0
Totale 1.103